Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. (HKG:1349)
2.450
+0.070 (2.94%)
Jun 1, 2026, 4:08 PM HKT
-16.95% (1Y)
| Market Cap | 6.67B -3.0% |
| Revenue (ttm) | 744.45M -11.7% |
| Net Income | -173.22M |
| EPS | -0.17 |
| Shares Out | 1.04B |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | 0.03 (1.35%) |
| Ex-Dividend Date | Jul 10, 2025 |
| Volume | 1,462,000 |
| Open | 2.350 |
| Previous Close | 2.380 |
| Day's Range | 2.350 - 2.470 |
| 52-Week Range | 2.350 - 5.290 |
| Beta | 0.14 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 12, 2026 |